Accéder au contenu
Merck

Evaluation and management of acquired methemoglobinemia associated with topical benzocaine use.

American journal of cardiovascular drugs : drugs, devices, and other interventions (2013-05-23)
Mohammed Taleb, Zubair Ashraf, Shahul Valavoor, Jodi Tinkel
RÉSUMÉ

Benzocaine is a widely used topical oropharyngeal anesthetic and has been reported to cause methemoglobinemia. We discuss benzocaine-induced methemoglobinemia and review the causes, presentation, and management of this serious complication. Treatment with methylene blue will result in reversal of methemoglobinemia and clinical recovery in most cases but needs to be used at appropriate doses in carefully selected individuals. Physicians who perform procedures involving the application of benzocaine for topical anesthesia need to rapidly identify and treat methemoglobinemia to avoid significant associated morbidity and mortality.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Benzocaine, ≥99% (HPLC)
Sigma-Aldrich
Ethyl 4-aminobenzoate, 98%
Supelco
Benzocaine, Pharmaceutical Secondary Standard; Certified Reference Material
Benzocaine, European Pharmacopoeia (EP) Reference Standard